J Korean Neurol Assoc.
2010 May;28(2):81-84.
Focused Update of 2009 Korean Clinical Practice Guidelines for the Antiplatelet Therapy in Secondary Prevention of Stroke
- Affiliations
-
- 1Department of Neurology, Seoul National University College of Medicine, Seoul, Korea.
- 2Department of Neurology, Hallym University College of Medicine, Anyang, Korea. ykh1030@hallym.ac.kr
- 3Department of Neurology, Inje University College of Medicine, Goyang, Korea.
- 4Department of Neurology, Inha University College of Medicine, Incheon, Korea.
- 5Department of Neurology, Yonsei University College of Medicine, Seoul, Korea.
- 6Department of Neurology, Ulsan University College of Medicine, Seoul, Korea.
- 7Department of Neurosurgery, Seoul National University College of Medicine, Seoul, Korea.
Abstract
- The aim of this update of Korean clinical practice guidelines for stroke is to provide timely evidence-based recommendations on the antiplatelet therapy in secondary prevention of stroke. Evidence-based recommendations are included for the use of antiplatelet agents for noncardioembolic stroke. Changes in the guidelines necessitated by new evidence will be continuously reflected in the new guideline.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Antiplatelet Therapy for Secondary Stroke Prevention in Patients with Ischemic Stroke or Transient Ischemic Attack
- Antiplatelet Therapy for Secondary Stroke Prevention: 2012 Focused Update of Korean Clinical Practice Guidelines for Stroke
- Pharmacological Secondary Prevention of Ischemic Stroke
- Review of Evidences and Updates of the Korean Clinical Practice Guidelines for Stroke in 2013
- How well Do We Prevent Cardioembolic Stroke?
